Hologic Inc (HOLX)

Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell

$55.18

Buy

$56.32

arrow-up$0.38 (+0.69%)

Prices updated at 15 May 2025, 21:34 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Hologic Inc develops, manufactures and supplies diagnostics products, medical imaging systems and surgical products for women's health. Its products are used in diagnosis of human diseases and screen donated human blood and plasma.
NASDAQ
arrow-down-0.18%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Chairman
Mr. Stephen P. Macmillan
CEO
Mr. Stephen P. Macmillan
Most recent earnings
30 Sep 2024
Fiscal year end
30 Sep 2024
Employees
7,063
Head office
250 Campus Drive
Marlborough
United States
01752
mobile
+1 508 263-2900
letter
ryan.simon@hologic.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. Scott T. Garrett
Independent Director
0.11m
Dr. Martin D. Madaus,PhD
Director
-
Ms. Sally Wellinghoff Crawford
Independent Director
0.12m
Mr. Wayde D. McMillan
Director
-
Mr. Charles J. Dockendorff
Independent Director
0.12m
Ms. Diana De Walt
Senior Vice President, Human Resources
-
Mr. Stephen P. Macmillan
Chairman of the Board, Chief Executive Officer and President
1.21m
Ms. Amy A. Wendell
Lead Independent Director
0.12m
Ms. Karleen M. Oberton
Chief Financial Officer
0.69m
Ms. Stacey D. Stewart
Independent Director
0.09m
Dr. Ludwig N. Hantson, PhD
Independent Director
0.09m
Ms. Christiana Stamoulis, M.B.A.
Independent Director
0.09m
Mr. Benjamin J. Cohn
Vice President, Corporate Controller and Principal Accounting Officer
-
Mr. Essex D. Mitchell
Chief Operating Officer
0.59m
Mr. Jan Verstreken
Group President, International
0.69m
Ms. Jennifer Schneiders
President, Diagnostics Solutions
-
Ms. Nanaz Mohtashami
Independent Director
0.09m
Mr. Brandon Schnittker
Division President, GYN Surgical Solutions
-
Mr. Mark Horvath
Division President, Breast and Skeletal Health Solutions
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Vanguard Group Inc26,815,519
BlackRock Inc21,364,833
T. Rowe Price Investment Management,Inc.17,938,833
T. Rowe Price12,663,176
Morgan Stanley - Brokerage Accounts10,498,533

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
13 Dec 2024-
09 Dec 2024-
04 Dec 2024-
04 Dec 2024-
04 Dec 2024-
04 Dec 2024-
04 Dec 2024-
04 Dec 2024-
04 Dec 2024-
04 Dec 2024-
04 Dec 2024-
14 Nov 2024-
14 Nov 2024-
14 Nov 2024-
14 Nov 2024-
14 Nov 2024-
14 Nov 2024-
14 Nov 2024-
14 Nov 2024-
14 Nov 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.